Insider Transactions in Q2 2025 at Regulus Therapeutics Inc. (RGLS)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2025
|
Stelios Papadopoulos |
SELL
Sale (or disposition) back to the issuer
|
Direct |
64,635
-100.0%
|
-
|
|
Jun 25
2025
|
Stelios Papadopoulos |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
976,253
-93.79%
|
-
|
|
Jun 25
2025
|
Pascale Witz |
SELL
Sale (or disposition) back to the issuer
|
Direct |
67,233
-100.0%
|
-
|
|
Jun 25
2025
|
William H Rastetter |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
57,292
-100.0%
|
-
|
|
Jun 25
2025
|
William H Rastetter |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
44,264
-43.59%
|
-
|
|
Jun 25
2025
|
Joseph P Hagan Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
571,558
-100.0%
|
-
|
|
Jun 25
2025
|
Christopher Ray Aker Sr. VP & General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
83,125
-100.0%
|
-
|
|
Jun 25
2025
|
Christopher Ray Aker Sr. VP & General Counsel |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
60,796
-42.24%
|
-
|
|
Jun 25
2025
|
Preston Klassen President & Head of R & D |
SELL
Sale (or disposition) back to the issuer
|
Direct |
115,555
-100.0%
|
-
|
|
Jun 25
2025
|
Hugh Rosen |
SELL
Sale (or disposition) back to the issuer
|
Direct |
57,292
-100.0%
|
-
|
|
Jun 25
2025
|
Hugh Rosen |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
6,979
-10.86%
|
-
|
|
Jun 25
2025
|
Kathryn J Collier |
SELL
Sale (or disposition) back to the issuer
|
Direct |
75,565
-100.0%
|
-
|
|
Jun 25
2025
|
Alice Shih Hou Huang |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
57,292
-100.0%
|
-
|
|
Jun 25
2025
|
Alice Shih Hou Huang |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
27,377
-32.33%
|
-
|
|
Jun 25
2025
|
Alice Shih Hou Huang |
SELL
Sale (or disposition) back to the issuer
|
Direct |
57,292
-100.0%
|
-
|
|
Jun 25
2025
|
Alice Shih Hou Huang |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,208
-8.33%
|
-
|
|
Jun 25
2025
|
Jason Raleigh Nunn |
SELL
Sale (or disposition) back to the issuer
|
Direct |
62,500
-100.0%
|
-
|
|
Jun 25
2025
|
David Baltimore |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
57,292
-100.0%
|
-
|
|
Jun 25
2025
|
David Baltimore |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
5,208
-8.33%
|
-
|
|
Jun 25
2025
|
David Baltimore |
SELL
Sale (or disposition) back to the issuer
|
Direct |
57,292
-100.0%
|
-
|
|
Jun 25
2025
|
David Baltimore |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
27,377
-32.33%
|
-
|
|
Jun 25
2025
|
Crispina Calsada Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
140,228
-100.0%
|
-
|
|
Jun 17
2025
|
Kathryn J Collier |
BUY
Exercise of conversion of derivative security
|
Direct |
4,929
+3.7%
|
$44,361
$9.35 P/Share
|
|
Jun 16
2025
|
Kathryn J Collier |
BUY
Exercise of conversion of derivative security
|
Direct |
1,396
+2.02%
|
$12,564
$9.9 P/Share
|
|
Jun 03
2025
|
Preston Klassen President & Head of R & D |
BUY
Open market or private purchase
|
Direct |
12,000
+19.98%
|
$84,000
$7.99 P/Share
|
|
Apr 30
2025
|
Jason Raleigh Nunn |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+50.0%
|
-
|
|
Apr 30
2025
|
William H Rastetter |
BUY
Grant, award, or other acquisition
|
Indirect |
62,500
+38.1%
|
-
|
|
Apr 30
2025
|
Hugh Rosen |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+49.3%
|
-
|
|
Apr 30
2025
|
Kathryn J Collier |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+47.44%
|
-
|
|
Apr 30
2025
|
Pascale Witz |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+48.18%
|
-
|
|
Apr 30
2025
|
Alice Shih Hou Huang |
BUY
Grant, award, or other acquisition
|
Indirect |
62,500
+42.47%
|
-
|
|
Apr 30
2025
|
Alice Shih Hou Huang |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+50.0%
|
-
|
|
Apr 30
2025
|
David Baltimore |
BUY
Grant, award, or other acquisition
|
Indirect |
62,500
+50.0%
|
-
|
|
Apr 30
2025
|
David Baltimore |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+42.47%
|
-
|
|
Apr 30
2025
|
Stelios Papadopoulos |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+5.66%
|
-
|